tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 222 are a BUY (88.1%), 22 are a HOLD (8.73%), 8 are a SELL (3.17%).
Analyst Mitchell Kapoor, carries an average stock price target met ratio of 35.75% that have a potential upside of 30.55% achieved within 56 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.
Mitchell Kapoor’s has documented 496 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VERV, Verve Therapeutics at 18-Jun-2025.
Analyst best performing recommendations are on SMMT (SUMMIT THERAPEUTICS PLC).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $30 was fulfilled within 4 days with a profit of $10.86 (56.74%) receiving and performance score of 141.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$36
$-0.01 (-0.03%)
$36
2 years 6 months 24 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Hold
$36
$-0.01 (-0.03%)
$35
2 years 6 months 30 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Hold
$36
$-0.01 (-0.03%)
2 years 6 months 30 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Hold
$36
$-0.01 (-0.03%)
$30
2 years 6 months 30 days ago
(22-Nov-2022)
2/2 (100%)
$0.4 (1.12%)
258
Hold
$36
$-0.01 (-0.03%)
$25
2 years 7 months ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor is most bullish on?
Which stock is Mitchell Kapoor is most reserved on?
What Year was the first public recommendation made by Mitchell Kapoor?
